D. Howe

发表

Expression of ZAP‐70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease: response to Smolej et al.

S. Johnson, G. Gibbs, T. Bromidge, 2008 .

Letter to the Editor

S. Johnson, G. Gibbs, T. Bromidge, 2007 .

ZAP-70 expression remains stable in chronic lymphocytic leukaemia.

S. Johnson, G. Gibbs, T. Bromidge, 2007, International journal of laboratory hematology.

Absence of minimal residual disease detectable by FACS, Southern blot or PCR in patients with chronic lymphocytic leukaemia treated with fludarabine.

M. J. Phillips, S. Johnson, D. Richardson, 1994, Acta oncologica.

Screening of the entire coding region of p53 in low grade lymphoproliferative disorders

T. Bromidge, D. Howe, 2000, Molecular pathology : MP.

In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues – correlation with clinical course

Sandra K. Johnson, T. Bromidge, D. Howe, 1998, Leukemia.

Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory.

S. Johnson, G. Gibbs, T. Bromidge, 2005, Clinical and laboratory haematology.

Simultaneous analysis of cell surface antigens and DNA content by flow cytometry.

M. J. Phillips, S. Johnson, D. Howe, 2008, Clinical and laboratory haematology.

Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and Morphology.

M. J. Phillips, S. Johnson, A. Paxton, 1997, Hematology.

Spectrum of p53 mutations in low-grade B-cell malignancies

S. Johnson, T. Bromidge, D. Howe, 2008, Leukemia.

Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell size.

S. Johnson, T. Bromidge, D. Howe, 1997, Molecular pathology : MP.